Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: LEIDOS BIOMEDICAL RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-19 to 2025-12-31
Current total value of award: $6142134
Description: NIAID-DMID-ANTIVIRAL PROGRAM FOR PANDEMICS EARLY PHASE CLINICAL TRIAL(S)